Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is P and Author is Punatar, Sachin  [Clear All Filters]
Journal Article
Zanwar S, Jain P, Gokarn A, Devadas SKumar, Punatar S, Khurana S, Bonda A, Pruthy R, Bhat V, Qureshi S, et al. Antibiotic Lock Therapy for Salvage of Tunneled Central Venous Catheters with Catheter Colonization and Catheter-Related Bloodstream Infection. Transpl Infect Dis. 2018:e13017.
Punatar S, Gupta A, Gawande J, Bagal B, Mathew L, Kannan S, Khattry N. Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome. Indian J Hematol Blood Transfus. 2016;32(1):32-38.
Gupta A, Punatar S, Mathew L, Kannan S, Khattry N. Cyclosporine Plus Methotrexate or Cyclosporine Plus Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Acute Leukemia Transplant: Comparison of Toxicity, Engraftment Kinetics and Transplant Outcome. Indian J Hematol Blood Transfus. 2016;32(3):248-256.
Chichra A, Nayak L, Kothari R, Kalantri S, Bonda A, Gokarn A, Punatar S, Mirgh S, Jindal N, Bagal B, et al. Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Int J Hematol. 2023.
Kumbhalwar K, Punatar S, Gokarn A, Nayak L, Chichra A, Mirgh S, Jindal N, Mathew L, Khattry N. Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant. Blood Cell Ther. 2023;6(3):95-103.
Punatar S, Kalantri SA, Chichra A, Agrawal AKumar, Nayak L, Bonda A, Gokarn A, Bagal B, Mathew L, Kannan S, et al. Pre-transplant use of tyrosine kinase inhibitors and transplant associated thrombotic microangiopathy - a single centre analysis of incidence, risk factors and outcomes. Bone Marrow Transplant. 2021.
Jindal N, Saroha M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Chavan P, et al. Relevance of vitamin D in patients undergoing HLA matched allogeneic stem cell transplant for acute leukemia. Transpl Immunol. 2023:101925.
Gupta A, Punatar S, Gawande J, Mathew L, Bagal B, Kannan S, Khattry N. Risk Factors, Pattern and Clinical Outcome of Acute Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplant. Indian J Hematol Blood Transfus. 2015;31(4):404-412.
Gupta SKumar, Gohil D, Dutta D, Panigrahi GCh, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RKumar, Chichra A, et al. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. Int Immunopharmacol. 2023;121:110437.